BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36335987)

  • 1. LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis.
    Xia X; Li Z; Li Y; Ye F; Zhou X
    J Gynecol Oncol; 2022 Nov; 33(6):e81. PubMed ID: 36335987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
    Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
    Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway.
    Hu Z; Cai M; Zhang Y; Tao L; Guo R
    Cell Cycle; 2020 Jan; 19(2):193-206. PubMed ID: 31885310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA XIST knockdown suppresses the growth of colorectal cancer cells via regulating microRNA-338-3p/PAX5 axis.
    Li W; He Y; Cheng Z
    Eur J Cancer Prev; 2021 Mar; 30(2):132-142. PubMed ID: 32826710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Liu X; Xie S; Zhang J; Kang Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
    [No Abstract]   [Full Text] [Related]  

  • 6. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA XIST confers aggressive progression via miR-361-3p/STX17 in retinoblastoma cells.
    Yang LL; Li Q; Zhang X; Cao T
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10433-10444. PubMed ID: 33155266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of lncRNA XIST promotes proliferation and differentiation, limits apoptosis of osteoblasts through regulating miR-203-3p/ZFPM2 axis.
    Niu S; Xiang F; Jia H
    Connect Tissue Res; 2021 Jul; 62(4):381-392. PubMed ID: 32326773
    [No Abstract]   [Full Text] [Related]  

  • 10. Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a.
    Guo T; Yuan D; Zhang W; Zhu D; Xiao A; Mao G; Jiang W; Lin M; Wang J
    Hum Cell; 2021 Mar; 34(2):579-587. PubMed ID: 33400246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis.
    Wang YP; Li HQ; Chen JX; Kong FG; Mo ZH; Wang JZ; Huang KM; Li XN; Yan Y
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3190-3203. PubMed ID: 32271437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
    Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
    Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis.
    Zhao H; Wan J; Zhu Y
    Drug Des Devel Ther; 2020; 14():3417-3427. PubMed ID: 32904674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p.
    Wang C; Qi S; Xie C; Li C; Wang P; Liu D
    J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
    Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
    Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_FOXP1 promotes the growth and survival of high glucose-treated human trophoblast cells through the regulation of miR-508-3p/SMAD family member 2 pathway.
    Li M; Huang Y; Xi H; Zhang W; Xiang Z; Wang L; Li X; Guo H
    Endocr J; 2022 Sep; 69(9):1067-1078. PubMed ID: 35545535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GINS2 was regulated by lncRNA XIST/miR-23a-3p to mediate proliferation and apoptosis in A375 cells.
    Hao YQ; Liu KW; Zhang X; Kang SX; Zhang K; Han W; Li L; Li ZH
    Mol Cell Biochem; 2021 Mar; 476(3):1455-1465. PubMed ID: 33389496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA X-inactive specific transcript suppresses the progression of hepatocellular carcinoma through microRNA-221-3p-targeted regulation of O6-methylguanine-DNA methyltransferase.
    Chen Z; Qi L; Fu H; Ma L
    Bioengineered; 2022 May; 13(5):14013-14027. PubMed ID: 35723009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of lncRNA XIST Ameliorates IL-1
    Cao G; Zhou H; Wang D; Xu L
    Cardiovasc Ther; 2022; 2022():6256384. PubMed ID: 36474713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.